Axoltis Pharma

Axoltis Pharma, the operator of a biotechnology company, plans to treat patients with severe neurological disorders. The company's drug-assisted neurorepair therapy targets patients with traumatic degenerative diseases of the central nervous system, addressing high unmet medical needs, providing treatment for neurodegenerative diseases, and improving functional recovery and quality of life.